Table 1.

Characteristics of the source patients of long-term CTC cell lines.

Patient Number/Cell line ID	Primary Tumour	Sites of metastatic disease at blood draw	Treatment prior to blood sampling	CTC count (IsoFlux, 7.5 ml blood)	Key protein expression of cell line
20/UWG01CTC	Distal oesophageal high grade neuroendocrine carcinoma	Widespread bone, nodal, and hepatic	Chemoradiotherapy with carboplatin and paclitaxel to primary tumour and regional nodal disease	3	Synaptophysin+ CGA+ CD56+ EpCAM−Cytokeratin weak/low
41/UWG02CTC	Gastric adenocarcinoma	Bone and peritoneal	Nil	109	EpCAM+ Cytokeratin+ CD44+